tiprankstipranks
Trending News
More News >
Pharming Group (PHGUF)
OTHER OTC:PHGUF
US Market

Pharming Group (PHGUF) Income Statement

Compare
98 Followers

Pharming Group Income Statement

Last quarter (Q3 2025), Pharming Group's total revenue was $97.29M, an increase of 29.61% from the same quarter last year. In Q3, Pharming Group's net income was $7.55M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 286.89M$ 245.32M$ 205.62M$ 189.85M$ 228.39M
Gross Profit
$ 231.82M$ 220.10M$ 188.06M$ 169.67M$ 203.06M
Operating Expenses
$ 235.21M$ 225.49M$ 169.83M$ 156.72M$ 120.97M
Depreciation and Amortization
$ 10.21M$ 15.93M$ 13.19M$ 19.61M$ 8.31M
EBITDA
$ 13.18M$ 9.88M$ 33.53M$ 48.78M$ 92.11M
Operating Income
$ -3.39M$ -4.88M$ 18.23M$ 27.84M$ 82.09M
Other Income/Expenses
$ -4.46M$ -7.13M$ -3.25M$ -4.76M$ -18.33M
Pretax Income
$ -7.85M$ -12.01M$ 14.99M$ 22.03M$ 47.47M
Net Income
$ -10.64M$ -10.55M$ 13.67M$ 16.00M$ 37.75M
Per Share Metrics
Basic EPS
$ -0.02$ -0.01$ 0.02$ 0.02$ 0.05
Diluted EPS
$ -0.02$ -0.01$ 0.02$ 0.02$ 0.04
Weighted Average Shares Outstanding
689.19M 821.28M 883.93M 876.44M 853.42M
Weighted Average Shares Outstanding (Diluted)
689.19M 843.25M 883.93M 876.44M 853.42M
Currency in USD

Pharming Group Earnings and Revenue History